Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.
Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization. Axelrad JE, et al. Among authors: hong s. Clin Gastroenterol Hepatol. 2020 Apr;18(4):872-880.e1. doi: 10.1016/j.cgh.2019.06.042. Epub 2019 Jul 11. Clin Gastroenterol Hepatol. 2020. PMID: 31302306 Free PMC article.
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease.
Haberman RH, Um S, Axelrad JE, Blank RB, Uddin Z, Catron S, Neimann AL, Mulligan MJ, Herat RS, Hong SJ, Chang S, Myrtaj A, Ghiasian G, Izmirly PM, Saxena A, Solomon G, Azar N, Samuels J, Golden BD, Rackoff P, Adhikari S, Hudesman DP, Scher JU; SAGA investigators. Haberman RH, et al. Among authors: hong sj. Lancet Rheumatol. 2022 Jun;4(6):e384-e387. doi: 10.1016/S2665-9913(22)00069-8. Epub 2022 Apr 1. Lancet Rheumatol. 2022. PMID: 35403000 Free PMC article. No abstract available.
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.
Hong SJ, Bhattacharya S, Aboubakr A, Nadkarni D, Lech D, Ungaro RC, Agrawal M, Hirten RP, Greywoode R, Mone A, Chang S, Hudesman DP, Ullman T, Sultan K, Lukin DJ, Colombel JF, Axelrad JE. Hong SJ, et al. Therap Adv Gastroenterol. 2022 Nov 4;15:17562848221132363. doi: 10.1177/17562848221132363. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36348637 Free PMC article.
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study.
Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S; Rising Educators Academics and Clinicians Helping-IBD (REACH-IBD). Holmer AK, et al. Among authors: hong s. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1598-1606.e5. doi: 10.1016/j.cgh.2023.01.002. Epub 2023 Jan 13. Clin Gastroenterol Hepatol. 2023. PMID: 36642291
21,095 results
You have reached the last available page of results. Please see the User Guide for more information.